TL;DR
This study provides strong epidemiological evidence for a positive association between hypertension and an increased risk of developing urinary bladder (UB) cancer. Using a large, propensity score-matched cohort, researchers found that individuals with hypertension had a statistically significant higher risk of UB cancer, particularly women.
What Problem Does This Paper Address?
Hypertension is a widespread global health issue, and its links to various medical conditions are increasingly being investigated. While previous studies have explored the association between hypertension and cancer, the results regarding urinary bladder (UB) cancer have been inconclusive. UB cancer is a significant health concern, and understanding its risk factors is crucial for prevention and early detection. This paper aims to clarify the relationship between hypertension and UB cancer by leveraging a large-scale, population-based cohort study with robust statistical matching.
Methods
The researchers employed a population-based cohort study design using data from Taiwan's National Health Insurance Research Database (NHIRD). A key methodological innovation was the use of propensity score matching (PSM). This technique was used to create two comparable groups: one with essential hypertension and a control group without hypertension. PSM aimed to balance the groups across several important characteristics, including age, sex, index date, and common medical comorbidities like diabetes mellitus, chronic kidney disease, and gout. This rigorous matching process helps to minimize confounding factors and isolate the effect of hypertension.
For outcome assessment, incident UB cancer was defined using International Classification of Diseases, Ninth Edition, with Clinical Modification (ICD-9-CM) codes, validated by procedure codes for diagnosis and treatment. Statistical analysis involved multivariable Cox models to calculate adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs), and Kaplan-Meier curves were used to compare cumulative incidence. Sensitivity analyses were conducted to assess the impact of differential time lags in follow-up.
Datasets
The study utilized the Longitudinal Health Insurance Dataset 2000 (LHID2000) from Taiwan's National Health Insurance Research Database (NHIRD). This dataset contains comprehensive healthcare information for over 23 million enrollees, representing more than 99% of Taiwan's population. The dataset includes registration files and claims data for ambulatory care and inpatient expenditures. The authors note that the NHIRD has been validated for population research in cardiovascular diseases.
Key Insights and Ideas
- Hypertension as a potential risk factor for UB cancer: The study provides compelling evidence that hypertension is associated with an increased risk of developing UB cancer. This moves beyond previous inconclusive findings.
- Sex-specific risk: The increased risk of UB cancer associated with hypertension was particularly pronounced in women, suggesting potential biological or lifestyle differences in how hypertension impacts UB cancer development between sexes.
- Robust matching for confounding: The use of propensity score matching was critical in creating comparable groups, allowing for a more reliable assessment of hypertension's independent effect, even after accounting for common comorbidities.
- Sustained risk over time: Sensitivity analyses indicated that the increased risk of UB cancer in hypertensive individuals was sustained throughout the follow-up period, suggesting a consistent underlying association.
Key Results
- The study included 79,236 individuals (39,618 with hypertension and 39,618 controls) after propensity score matching.
- Over a total follow-up of 380,525 person-years for the hypertension group and 372,020 person-years for the control group, 248 hypertensive patients and 186 control patients developed UB cancer.
- This represented a 32% increase in the risk of UB cancer in the hypertension group (adjusted hazard ratio [aHR] = 1.32; 95% CI, 1.09-1.60).
- Hypertensive women showed a significantly increased risk (aHR = 1.55; 95% CI, 1.12–2.13) compared to non-hypertensive women.
- Men with hypertension had a statistically non-significant increased risk (aHR = 1.22; 95% CI, 0.96-1.55).
- Sensitivity analyses showed a sustained increased risk, with an aHR of 1.46 (95% CI, 1.09-1.97) for the seventh year of follow-up and beyond.
Limitations and Future Work
The authors acknowledge several limitations:
- Antihypertensive drug use: The study did not consider the impact of antihypertensive drugs, although a previous study using a similar dataset found no significant impact.
- Lifestyle and environmental factors: Data on smoking habits, environmental and occupational chemical carcinogen exposure, fruit and vegetable consumption, and physical activity were not available. While smoking-related diagnoses were controlled for, direct smoking status was not.
- Modest risk magnitude: The authors note that while statistically significant, the clinical relevance of a hazard ratio of 1.32 (representing a 32% increase) is considered modest.
Future work could focus on elucidating the underlying mechanisms linking hypertension and UB cancer, potentially through studies investigating oxidative stress, inflammation, and cell turnover pathways. Further research is also needed to understand why the risk appears to be more pronounced in women.
Summary updated